Ac2-26
An Annexin A1 (AnxA1)-derived N-terminal peptide used in inflammation-resolution research, with recent preclinical work in osteoarthritis models.
Tag
Inflammation
Pages related to Inflammation.
Tag
Pages related to Inflammation.
An Annexin A1 (AnxA1)-derived N-terminal peptide used in inflammation-resolution research, with recent preclinical work in osteoarthritis models.
A 2026 mouse study reports that Ac2‑26, an Annexin A1–derived pro‑resolving peptide, reduced pain-like sensitivity and several joint damage readouts in collagenase-induced osteoarthritis. It’s preclinical—but it illustrates the logic of “resolution pharmacology.”